Cytokinetics (CYTK) Q3 2024 Earnings

8AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.38
-1.17
-0.97
-0.76

Details

Expected EPS
-1.056574
Actual EPS
-1.31
Surprise EPS
-0.25
Surprise Percent
+23.99%

Description

Cytokinetics (CYTK) has reported earnings of -1.31 per share for Q3 2024.

0 Comments

Share your thoughts